Mozambique vs Tanzania: Population requiring preventive chemotherapy for schistosomiasis
Mozambique
18.41 million
in 2024
Tanzania
21.35 million
in 2024
Mozambique rank
4th
Tanzania rank
2nd
Population requiring preventive chemotherapy for schistosomiasis over time
- Mozambique
- Tanzania
How they compare
Tanzania currently reports 21.35 million against 18.41 million in Mozambique, a difference of 2.93 million.
That makes Tanzania's figure about 1.2 times Mozambique's.
The two have swapped places 5 times across 15 shared years of data; in 2010 it was Mozambique ahead.
Mozambique ranks 4th and Tanzania ranks 2nd of 52 countries.
Across the 2 decades both report, Mozambique averaged higher in 1 and Tanzania in 1.
Head to head by decade
| Decade | Mozambique | Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 13.93 million | 12.55 million | 1.38 million | Mozambique |
| 2020s | 18.10 million | 19.29 million | 1.18 million | Tanzania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Mozambique or Tanzania?
- Tanzania, at 21.35 million against 18.41 million in Mozambique as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Mozambique and Tanzania?
- 2.93 million, with Tanzania ahead.
- How many years of comparable data are there for Mozambique and Tanzania?
- 15 years are reported by both, from 2010 to 2024.
- How do Mozambique and Tanzania rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Mozambique ranks 4th and Tanzania ranks 2nd of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.